Schonfeld Strategic Advisors LLC Enanta Pharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $1.13 Million - $1.67 Million	23,415 New	23,415 $1.22 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $319,542 - $422,427	-5,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $343,083 - $555,009	5,700 New	5,700 $426,000
Q2 2020 Aug 14, 2020	SELL	$46.37 - $57.58 $228,372 - $283,581	-4,925 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$40.22 - $62.0 $198,083 - $305,350	4,925 New	4,925 $253,000
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $293,392 - $381,570	-6,427 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $243,647 - $300,783	6,427	6,427 $301,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.